CagriSema dosing schedule The CagriSema dosing protocol follows a gradual titration designed to minimize gastrointestinal side effects while reaching the full therapeutic dose
BPC-157 is used for accelerating recovery from muscle, tendon, and ligament injuries, healing gastrointestinal tissue damage, reducing inflammation, and promoting tissue repair in bodybuilders and athletes
Saline or Sterile Water A carrier solution to ensure safe and effective delivery of the vitamin
Neurotrauma 37 , 347356 (2020)
As a general clinical principle: Retest HbA1c no sooner than three months after commencing B12 replacement therapy, and ideally once haematological recovery has been confirmed Confirm haematological recovery normalisation of MCV and haemoglobin before interpreting the repeat HbA1c as reliable Use interim glucose monitoring such as fasting plasma glucose, OGTT, or self-monitored blood glucose (SMBG) to assess glycaemic control during the treatment period